Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
publishDate:"[2000 TO 2009]"
journalStr:"ClinicalTrials.gov"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2000+TO+2009%5D%22&filter%5B%5D=journalStr%3A%22ClinicalTrials.gov%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (54)
1
A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma : "Phase II Multicenter, Open-Label, Clinical and Pharmacokinetic Study of Aplidin® As A 3-Hour Infusion Every 2 Weeks Alone or in Combination With Dexamethasone, in Pre-Treated Patients With Relapsing or Refractory Multiple Myeloma."
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
2
Efficacy and Safety of Zoledronic Acid in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma : A Randomized, Double-blind, Multi-centre Study to Evaluate the Fficacy and Safety of Zometa as a Treatment in Patients With Bone Metastases of Any Solid Tumors or Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
3
TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma : Phase 1 Dose Escalating Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TKI258 in Subjects With Refractory or Relapsed Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
4
Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma : Vaccination With Idiotype-KLH Loaded Dendritic Cells. A Phase I Study for Patients With Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
5
Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma : Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Subjects With Advanced Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
6
VELCADEXA: Velcade and Dexamethasone in Multiple Myeloma : VELCADEXA: A National, Multi-Center, Open-Label Study of Pretransplant Induction With Alternating VELCADE and Dexamethasone (VEL/Dex) in Younger (< 65 Yrs) Untreated Multiple Myeloma Patients.
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
7
GEM05 for Patients With Multiple Myeloma Under 65 Years : A National, Open-Label, Multicenter, Randomized, Comparative Phase III Study of Induction Treatment With VBMCP-VBAD/Velcade Versus Thalidomide / Dexamethasone Versus Velcade / Thalidomide / Dexamethasone Followed by High Dose Intensive Therapy With Autologous Hemopoietic Stem Cell Support and Maintenance Treatment With Interferon-a Versus Thalidomide Versus Thalidomide / Velcade in Untreated Patients With Multiple Myeloma Less Than 65 Yrs Old
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
8
Safety and Efficacy Study of Imexon for Treatment of Multiple Myeloma Patients : A Phase 1/2 Trial of Amplimexon® (Imexon, Inj.) for Patients With Previously Treated Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
9
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) : Clinical Phase II Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
10
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma : A Multicenter Phase I/II Trial Evaluating the Safety and Efficacy of Lenalidomide (Revlimid, CC-5013) in Combination With Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2009
Wird geladen...
1
2
3
4
5
6
Nächster »
[6]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2000-2009
Filter aufheben
Zeitschrift: ClinicalTrials.gov
Medienart
54
Aufsätze
54
E-Artikel
54
E-Ressourcen
Zeitschriftentitel
ClinicalTrials.gov
Thema
54
610
54
Multiple Myeloma
51
Study Type: Interventional
43
Neoplasms, Plasma Cell
36
Medical Condition: Multiple Myeloma
31
Recruitment Status: Completed
22
Phase: Phase 2
18
Recruitment Status: Unknown status
13
Phase: Phase 3
9
Phase: Phase 1
4
Leukemia
4
Phase: Phase 1/Phase 2
4
Recruitment Status: Terminated
3
Leukemia, Myeloid, Acute
3
Lymphoma
3
Myelodysplastic Syndromes
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Study Type: Observational
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Phase: Phase 2/Phase 3
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2000-2009
24
2009
12
2008
3
2007
15
2006
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
54
Englisch
Haven't found what you're looking for?
Wird geladen...